You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 4, April 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Alzheimer Disease
 •Neurogenetics
 •Alert me on articles by topic

Measuring the Risk of Alzheimer Disease

Roger N. Rosenberg, MD, Editor

Arch Neurol. 2007;64(4):479-480.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

All is created and goes according to order,
yet o'er our lifetime rules an uncertain fate.
—Johann Wolfgang von Goethe1

In recent years, there have been hundreds of published reports citing or refuting a genetic association of specific susceptibility genes and the occurrence of Alzheimer disease (AD).2-6 It is clear that mutations in the amyloid precursor protein (APP) gene (chromosome 21), presenilin 1 gene (chromosome 14), and presenilin 2 gene (chromosome 1) are causal of AD.7 It is also well established that the {varepsilon}4 allele of apolipoprotein E is a major susceptibility factor for AD.2, 4-5,7 However, a clear consensus of other potential susceptibility genes for AD remains to be reached. Progress in this regard has been achieved by Bertram et al,2 who have collected systematic analyses of AD genetic association studies in the AlzGene database, a publicly available, updated database that catalogs all genetic association . . . [Full Text of this Article]

AUTHOR INFORMATION


RELATED ARTICLE

The Association Between Genetic Variants in SORL1 and Alzheimer Disease in an Urban, Multiethnic, Community-Based Cohort
, , , , , , , , , , and
Arch Neurol. ;64():501-506.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.